Lixte Biotechnology Holdings, Inc.
Cover
DOCUMENT AND ENTITY INFORMATION
Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical]
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Notes to Financial Statements
Basis of Presentation
Organization and Business Operations
Summary of Significant Accounting Policies
Share Exchange Agreement, Private Placements and Common Stock Warrants
Money Market Funds - Fair Value
Related Party Transactions
Stock-Based Compensation
Commitments and Contingencies
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Summary of Significant Accounting Policies (Tables)
Share Exchange Agreement, Private Placements and Common Stock Warrants (Tables)
Money Market Funds - Fair Value (Tables)
Stock-Based Compensation (Tables)
Commitments and Contingencies (Tables)
Notes Details
Organization and Business Operations (Details Textual)
Summary of Significant Accounting Policies (Details)
Summary of Significant Accounting Policies (Details Textual)
Share Exchange Agreement, Private Placements and Common Stock Warrants (Details)
Share Exchange Agreement, Private Placements and Common Stock Warrants (Details 1)
Share Exchange Agreement, Private Placements and Common Stock Warrants (Details Textual)
Money Market Funds - Fair Value (Details)
Money Market Funds - Fair Value (Details Textual)
Related Party Transactions (Details Textual)
Stock-Based Compensation (Details)
Stock-Based Compensation (Details 1)
Stock-Based Compensation (Details Textual)
Commitments and Contingencies (Details)
Commitments and Contingencies (Details Textual)
All Reports
Filing Date:
05-09-2013
Form Type:
Form 10-Q
Description:
Quarterly Report